LivaNova PLC (NASDAQ:LIVN) Receives $67.17 Average Target Price from Analysts

Shares of LivaNova PLC (NASDAQ:LIVN) have been assigned a consensus rating of “Moderate Buy” from the six research firms that are covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $65.83.

A number of equities research analysts recently issued reports on the stock. Robert W. Baird decreased their price objective on shares of LivaNova from $57.00 to $55.00 and set a “neutral” rating for the company in a report on Thursday, August 1st. Needham & Company LLC upped their price objective on shares of LivaNova from $72.00 to $75.00 and gave the stock a “buy” rating in a report on Wednesday, July 31st. Mizuho upped their price objective on shares of LivaNova from $75.00 to $80.00 and gave the stock a “buy” rating in a report on Thursday, May 2nd. StockNews.com raised shares of LivaNova from a “hold” rating to a “buy” rating in a research report on Thursday, April 25th. Finally, Stifel Nicolaus boosted their target price on shares of LivaNova from $70.00 to $72.00 and gave the stock a “buy” rating in a research report on Thursday, July 25th.

Insider Activity

In related news, Director Daniel Jeffrey Moore sold 56,623 shares of the stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $60.11, for a total value of $3,403,608.53. Following the completion of the transaction, the director now owns 27,534 shares of the company’s stock, valued at $1,655,068.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.27% of the stock is owned by company insiders.

Institutional Trading of LivaNova

Several large investors have recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in shares of LivaNova in the fourth quarter valued at approximately $26,064,000. Great Lakes Advisors LLC bought a new position in shares of LivaNova during the second quarter worth $16,614,000. Mesirow Institutional Investment Management Inc. bought a new stake in LivaNova in the 1st quarter valued at $13,816,000. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in LivaNova in the 4th quarter valued at $8,330,000. Finally, Magnetar Financial LLC lifted its position in LivaNova by 24.5% in the 1st quarter. Magnetar Financial LLC now owns 753,338 shares of the company’s stock valued at $42,142,000 after acquiring an additional 148,178 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

LivaNova Trading Up 1.3 %

Shares of NASDAQ:LIVN opened at $45.82 on Wednesday. The stock has a market capitalization of $2.48 billion, a PE ratio of -76.37 and a beta of 0.99. LivaNova has a 1 year low of $42.75 and a 1 year high of $64.47. The firm has a fifty day moving average price of $53.73 and a 200 day moving average price of $54.39. The company has a current ratio of 3.45, a quick ratio of 2.71 and a debt-to-equity ratio of 0.49.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.